Status:
COMPLETED
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Lead Sponsor:
Northern California Institute of Research and Education
Collaborating Sponsors:
U.S. Army Medical Research and Development Command
Conditions:
Healthy Volunteers
Eligibility:
All Genders
19-39 years
Phase:
NA
Brief Summary
In recent years, there has been increased focus on cognitive side effects of sleep-inducing medications that may contribute to unusual behavior during unexpected awakenings during the night. Concerns ...
Detailed Description
Up to 216 healthy volunteers will be enrolled to participate in the 10 day study. After screening procedures have been completed (at SFVAMC), Days 1 - 7 will take place in subjects' homes, where their...
Eligibility Criteria
Inclusion
- To participate in the study, participants must:
- Be between the ages of 19 and 39
- Be in good physical health
- Be a good sleeper with consistent bedtimes and wake times
- Not have problems falling or staying asleep
- Be a non-smoker
- Meet our other study criteria
Exclusion
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT01243060
Start Date
May 1 2011
End Date
July 1 2014
Last Update
October 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Veterans Affairs Medical Center
San Francisco, California, United States, 94121